Prados et al., 2008 - Google Patents
JA Marchal, C. Velez, AR Rama1, F. Rodriguez-Serrano3, O. Caba3, A. Martinez, F. Hita3, M. Peran3Prados et al., 2008
- Document ID
- 9334432360300528147
- Author
- Prados J
- Melguizo R
- Boulaiz E
- Publication year
- Publication venue
- New Gene Therapy and Cancer Research
External Links
Snippet
Breast cancer research has developed at a rapid pace over the past few decades, leading to longer survival times for breast cancer patients and opening up the possibility of developing curative treatments for advanced breast cancer. Hopes for individualized treatments have …
- 101150101086 Ska3 gene 0 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/04—Uses of viruses as vector in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bateman et al. | Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth | |
| Roth et al. | Gene therapy for cancer: what have we done and where are we going? | |
| CA2371922C (en) | Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases | |
| Liu et al. | Gene therapy in pancreatic cancer | |
| Rouanet et al. | Gene therapy for pancreatic cancer: specificity, issues and hopes | |
| JP2012001566A (en) | Method for treating solid tumor and metastasis by gene therapy | |
| Gregg et al. | Considering the potential for gene-based therapy in prostate cancer | |
| AU2002303247B2 (en) | Chemotherapeutic induction of Egr-1 promoter activity | |
| AU2002303247A1 (en) | Chemotherapeutic induction of Egr-1 promoter activity | |
| Cusack et al. | Introduction to cancer gene therapy | |
| EP3400024B1 (en) | A combination therapy using reic/dkk-3 gene and a checkpoint inhibitor | |
| Albelda et al. | Gene therapy for lung neoplasms | |
| Prados et al. | J. A. Marchal, C. Velez, A. R. Rama1, F. Rodriguez-Serrano3, O. Caba3, A. Martinez, F. Hita3, M. Peran3 | |
| Kirby et al. | Gene therapy for ovarian cancer: progress and potential | |
| KR20060096023A (en) | Cancer gene therapy | |
| KR102471898B1 (en) | Tumor-targeting trans-splicing ribozyme expressing immune checkpoint inhibitor and use thereof | |
| CN116670172A (en) | Cancer-specific trans-splicing ribozymes expressing immune checkpoint inhibitors and uses thereof | |
| Ardelt et al. | Molecular aspects of bladder cancer IV: gene therapy of bladder cancer | |
| Singh et al. | GENE THERAPY FOR ORAL CANCER-JOURNEY TO A NEW HORIZON. | |
| JP2010536380A (en) | Methods and compositions for post-transcriptional gene silencing | |
| Tan et al. | The evolving role of gene-based treatment in surgery | |
| US20230390320A1 (en) | Cancer-specific trans-splicing ribozyme expressing immune checkpoint inhibitor, and use thereor | |
| Gdor et al. | Gene therpay for prostate cancer | |
| Szlosarek et al. | Potential applications of gene therapy in the patient with cancer | |
| Toloza | Gene therapy for lung cancer |